The seven enigmas of SARS-CoV-2: From the past to the future
Authors:
- Evangelos AndreakosEAEvangelos Andreakos
- Lisa ArkinLALisa Arkin
- Paul BastardPBPaul Bastard
- Alexandre BolzeABAlexandre Bolze
- Alessandro BorghesiABAlessandro Borghesi
- Petter BrodinPBPetter Brodin
- Jean-Laurent CasanovaJCJean-Laurent Casanova
- Giorgio CasariGCGiorgio Casari
- Aurélie CobatACAurélie Cobat
- Beth DroletBDBeth Drolet
- Jacques FellayJFJacques Fellay
- Elena W.Y. HsiehEHElena W.Y. Hsieh
Open Access
- 24 October 2025
- journal article
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 1 (4)
Abstract
Five years ago, we launched the COVID Human Genetic Effort. Our goal was to explain the clinical variability among SARS-CoV-2–exposed individuals by searching for monogenic inborn errors of immunity and their phenocopies. We deciphered the pathogenesis of critical COVID-19 pneumonia and multisystem inflammatory syndrome in children in ∼15% and 2% of cases, respectively, thereby revealing general mechanisms of severe disease. We also defined neuro-COVID genetically and immunologically in one child, while we delineated the immunological mechanisms of COVID-toes in healthy children and young adults, paving the way for their genetic study. Understanding the human genetic and immunological basis of resistance to SARS-CoV-2 infection, long COVID, and myocarditis after mRNA vaccination has been challenging, and investigations remain ongoing. This work highlights the power of patient-based basic research and large-scale international collaborative efforts to discover human genetic and immunological drivers of infectious disease phenotypes, with implications for the timely development of new medical strategies before the next pandemic arrives.Keywords
This publication has 268 references indexed in Scilit:
- Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021JAMA Network Open, 2022
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease SeverityJAMA, 2021
- Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 PandemicJAMA Dermatology, 2021
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2JAMA Network Open, 2021
- Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19JAMA, 2021
- Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 PandemicJAMA Dermatology, 2021
- Neurology and COVID-19JAMA, 2020
- Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicJAMA Dermatology, 2020
- Presence of Genetic Variants Among Young Men With Severe COVID-19JAMA, 2020
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2JAMA, 2020